Skip to main content

Clinical Trial Results

Search

Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

Tags: , ,